Researchers call for fix to pharmacy-level barriers to buprenorphine

Abstract

Exempting pharmacy orders of buprenorphine from investigative reports and eliminating prior authorization requirements for the medication are among the significant recommendations offered in an opinion piece calling for expanded access to the treatment.